Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Tyrosine Kinase

Items 51-60 of 351

Page
per page
  1. AZD-9291
    B1104 AZD-9291
     1 Citation
    Target: EGFR
    Summary: Mutated forms EGFR inhibitor
      ≥24.98 mg/mL
  2. CP-673451
    B2173 CP-673451
    Target: PDGFR
    Summary: PDGFRα/β inhibitor,potent and selective
  3. Mutant EGFR inhibitor
    B1103 Mutant EGFR inhibitor
    Summary: Selective Mutated EGFR inhibitor
      Soluble in DMSO
  4. AST-1306 TsOH
    B1020 AST-1306 TsOH
    Summary: ErbB2 and EGFR inhibitor
      Soluble in DMSO
  5. Tyrphostin 9
    B1494 Tyrphostin 9
    Summary: Selective EGFR/PDGFR inhibitor
      insoluble in H2O; ≥14.1 mg/mL
  6. SKLB1002
    B1305 SKLB1002
    Summary: VEGFR2 inhibitor,potent and ATP-competitve
  7. WZ3146
    A8881 WZ3146
    Summary: Mutant EGFR inhibitor, potent and irreversible
      ≥23.25 mg/mL
  8. Vandetanib (ZD6474)
    A8555 Vandetanib (ZD6474)
    Target: VEGFR|EGFR
    Summary: VEGFR2/EGFR antagonist
      insoluble in H2O; ≥11.88 mg/mL
  9. FIIN-2
    A8696 FIIN-2
    Target: FGFR
    Summary: Irreversible inhibitor of FGFR
      ≥31.75 mg/mL
  10. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    Target: EGFR|ErbB
    Summary: ErbB inhibitor
      ≥23.7 mg/mL

Items 51-60 of 351

Page
per page